Back
Kronos Worldwide 10K Form
Sell
31
KRO
Kronos Worldwide
Last Price:
$6.45
Seasonality Move:
1.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | KRO/Kronos Worldwide Quarterly |
2023-11-02 | 10Q | KRO/Kronos Worldwide Quarterly |
2023-08-02 | 10Q | KRO/Kronos Worldwide Quarterly |
2023-05-03 | 10Q | KRO/Kronos Worldwide Quarterly |
2022-11-02 | 10Q | KRO/Kronos Worldwide Quarterly |
2022-08-03 | 10Q | KRO/Kronos Worldwide Quarterly |
Receive KRO News And Ratings
See the #1 stock for the next 7 days that we like better than KRO
KRO Financial Statistics
Sales & Book Value
Annual Sales: | $1.9B |
---|---|
Cash Flow: | $-114.4M |
Price / Cash Flow: | 19.31 |
Annual Sales: | $7.36 |
Price / Book: | 0.88 |
Profitability
EPS (TTM): | 0.83000 |
---|---|
Net Income (TTM): | $96.2M |
Gross Margin: | $359.3M |
Return on Equity: | 11.85% |
Return on Assets: | 5.28% |
Kronos Worldwide Earnings Forecast
Key Kronos Worldwide Financial Ratios
-
The Gross Profit Margin over the past 22 years for KRO is 19.04%.
-
The Selling, General & Administrative Expenses for KRO have been equal to 11.95% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 49.77% of Operating Income.
-
The Net Earning history of KRO is 4.57% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 13 years.
Kronos Worldwide Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Chemicals |
Sector: | Materials |
Current Symbol: | KRO |
CUSIP: | 50105F |
Website: | kronosww.com |
Debt
Debt-to-Equity Ratio: | 0.66 |
---|---|
Current Ratio: | 2.62 |
Quick Ratio: | 0.87 |
Price-to-Earnings
Trailing P/E Ratio: | 8.63 |
---|---|
Forward P/E Ratio: | 5.75 |
KRO Technical Analysis vs Fundamental Analysis
Sell
31
Kronos Worldwide (KRO)
is a Sell
Is Kronos Worldwide a Buy or a Sell?
-
Kronos Worldwide stock is rated a SellThe current Kronos Worldwide [KRO] share price is $6.47. The Score for KRO is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.